PROPEL® mometasone furoate implant


Dr. Lomeo at Mercy Health Muskegon is among the first in the United States to offer patients with chronic sinusitis an innovative new technology, the PROPEL® mometasone furoate implant that is clinically proven to improve surgical outcomes for chronic sinusitis sufferers. Chronic sinusitis is a condition in which patients' sinuses become swollen and inflamed, leading to difficulty breathing, facial pain or headache, and loss of smell and taste. The condition is common, affecting 31 million people in the U.S., and greatly impacts quality of life.

Learn more.